Drug Search Results
More Filters [+]

Levonadifloxacin

Alternative Names: levonadifloxacin, wck-771, wck771, wck 771
Latest Update: 2024-04-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: DNA Damager

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India

Approved Indications: None

Known Adverse Events: None

Company: Wockhardt
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Levonadifloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Skin Diseases, Bacterial|Communicable Diseases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

W-771/2349-301

P3

Completed

Communicable Diseases|Skin Diseases, Bacterial

2018-09-25

75%

W 771/2349-101

P1

Completed

Healthy Volunteers

2013-06-01

WCK771/P-I/MD/08

P1

Completed

Healthy Volunteers

2012-02-07

28%

Recent News Events